Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study.

Gianni CarraroValentina Di VicoLoris MartinettiElisabetta BettinMartina CacciapuotiLucia Federica StefanelliLaura GobbiFederico NalessoFrancesca Katiana MartinoLorenzo Arcangelo Calò

Published in: Clinical drug investigation (2024)

Keyphrases

polycystic kidney disease
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
atrial fibrillation